Auspex Pharmaceuticals
Latest round
- Series E
Last raised
- Dec 2013
Total raised
- $63M
Investors
- 7
About Auspex Pharmaceuticals
Auspex Pharmaceuticals, Inc.Founded in 2001 and headquartered in the US, Auspex Pharmaceuticals, Inc. is dedicated to the research and development of biopharmaceuticals.Auspex Pharmaceuticals specializes in innovative biopharmaceuticals aimed at treating chronic disorders.14 mn.90 mn, the company is positioned to explore additional therapies and reach new markets, focusing on innovative solutions for neurological and autoimmune conditions. Teva's acquisition in May 2015 will support these strategic initiatives, ensuring a robust pipeline for future product launches.
Who invested in Auspex Pharmaceuticals
7 investors across 4 rounds
See all investors in Auspex Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Auspex Pharmaceuticals
Who invested in Auspex Pharmaceuticals?
Auspex Pharmaceuticals has 7 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Auspex Pharmaceuticals raised?
Auspex Pharmaceuticals has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Auspex Pharmaceuticals last raise money?
Auspex Pharmaceuticals's most recent round on record is a Series E, in Dec 2013.
What does Auspex Pharmaceuticals do?
Auspex Pharmaceuticals is a pharmaceuticals company.
Where is Auspex Pharmaceuticals headquartered?
Auspex Pharmaceuticals is headquartered in US.
Which VCs invest in companies like Auspex Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Auspex Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series E
Raising like Auspex Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.